Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Phase Two Ventures is a seed-stage venture fund based in San Diego that invests in early-stage startups developing foundational tools and technologies for life science R&D. Their portfolio includes companies focused on computational biology, genomics platforms, cell sorting technology, diabetes data management (Sweetspot Diabetes), and rapid molecular diagnostics (Mesa Biotech)[1][2][4]. Several of their investments have been acquired by major industry players such as Dexcom and Thermo Fisher[1].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Phase Two Ventures.